The Sarco assisted dying capsule, developed by nonprofit Exit International, has received legal approval in Switzerland. Designed to replace the current method of ingesting liquid sodium pentobarbital, it offers a new option for those seeking medical assistance in dying.
Switzerland maintains minimal legal restrictions on physician-assisted suicide. In 2020 alone, approximately 1,300 individuals—primarily those with terminal illnesses—chose this path. Comparable frameworks exist in other European nations, including Belgium, Germany, and the Netherlands.
To clarify: "Passive euthanasia" entails withholding life-prolonging treatments, such as refusing aggressive interventions. In contrast, physician-assisted suicide involves a medical professional actively and painlessly ending the patient's life at their request.
The prevailing method today requires swallowing liquid sodium pentobarbital, inducing sleep within 2-5 minutes, followed by coma and death. Though it ensures a peaceful passing, it relies on regulated substances.
Exit International, based in Australia, has pioneered the Sarco—a self-contained, 3D-printed capsule for assisted dying. Recently greenlit in Switzerland, per SwissInfo, its creator, Dr. Philip Nitschke (a former physicist), secured a favorable legal opinion from the country's medical examination committee last year.
As Dr. Nitschke explains, the Sarco can be activated from inside by the individual and towed to any location.
Once sealed, the capsule floods with nitrogen, slashing oxygen levels to about 1% within 30 seconds (from the normal 21%).
"The person may feel briefly disoriented or euphoric before losing consciousness," notes Dr. Nitschke. "Death follows in 5-10 minutes due to hypoxia and hypocapnia—no panic or suffocation occurs."
For now, a doctor's presence is mandatory for a psychiatric evaluation. However, Dr. Nitschke envisions an AI-based screening system ahead. "Psychiatrists remain skeptical," he acknowledges, "but one could envision an online test granting access codes."
Exit International anticipates deploying the first unit next year, pending refinements like cameras for consent recording and communication.
